Lodivixx tab. 5/160mg

DRUG3 trials

Sponsors

Hanlim Pharm. Co., Ltd.

Conditions

Healthy Male Subjects

Phase 1

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects

CompletedNCT01652339

Hanlim Pharm. Co., Ltd.Healthy Male Subjects

Start: 2012-07-31End: 2012-12-31Updated: 2013-03-26

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)

CompletedNCT01819779

Hanlim Pharm. Co., Ltd.Healthy Male Subjects

Start: 2013-03-31End: 2013-11-30Updated: 2018-08-03

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)

CompletedNCT03648333

Hanlim Pharm. Co., Ltd.Healthy Male Subjects

Start: 2013-12-31End: 2014-06-30Updated: 2018-08-27